Novel circulating tumor DNA (ctDNA) based ddPCR drop-off assays for improved Minimal Residual Disease (MRD) monitoring in Acute Myeloid Leukemia (AML)

被引：0
|
作者：
Rausch, C. [1 ]
Ziemann, F. [1 ]
Schneider, S. [1 ]
Subklewe, M. [1 ]
Spiekermann, K. [1 ]
Rothenberg-Thurley, M. [1 ]
Metzeler, K. H. [1 ]
机构：
[1] Ludwig Maximilian Univ Munchen, Lab Leukamiediagnost, Univ Klinikum, Med Klin & Poliklin 3, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P920
引用
收藏
页码：252 / 252
页数：1
相关论文
共 50 条
  • [41] Monitoring of Minimal Residual Disease in NPM1 Mutated Acute Myeloid Leukemia (AML): Results of the AML Study Group (AMLSG)
    Kroenke, Jan
    Schlenk, Richard
    Jensen, Kai-Ole
    Eiwen, Karina
    Habdank, Marianne
    Spaeth, Daniela
    Krauter, Juergen
    Ganser, Arnold
    Doehner, Hartmut
    Doehner, Konstanze
    BLOOD, 2008, 112 (11) : 260 - 260
  • [42] Prognostic impact of minimal residual disease (MRD) assessment in acute myeloid leukemia (AML) with mutated NPM1: Results of the AML study group (AMLSG)
    Kroenke, J.
    Schlenk, R. F.
    Jensen, K-O
    Eiwen, K.
    Onken, S.
    Habdank, M.
    Spaeth, D.
    Krauter, J.
    Ganser, A.
    Goehring, G.
    Schlegelberger, B.
    Luebbert, M.
    Wattad, M.
    Kindler, T.
    Salih, H. R.
    Mergenthaler, H-G
    Goetze, K.
    Doehner, H.
    Doehner, K.
    ONKOLOGIE, 2010, 33 : 136 - 136
  • [43] Molecular residual disease (MRD) detection using bespoke circulating tumor DNA (ctDNA) assays in localized soft tissue sarcoma (STS): A multicenter study
    Alshibany, Aisha
    Zhou, Maggie
    Warren, Emilie Ak
    Ganjoo, Kristen N.
    Demicco, Elizabeth
    Feeney, Jordan
    Lee, Jasmine
    Shultz, David Benjamin
    Spickard, Erik
    Bui, Nam
    Cardona, Kenneth
    Salawu, Abdulazeez
    Razak, Albiruni Ryan Abdul
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Next generation sequencing-based monitoring for minimal residual disease in acute myeloid leukemia
    Ok, Chi Young
    Salim, Alaa
    Luthra, Rajyalakshmi
    Patel, Keyur
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S196 - S196
  • [45] Minimal residual disease monitoring via AML1-ETO breakpoint tracing in childhood acute myeloid leukemia
    Chen, Xiaoyan
    Zong, Suyu
    Yi, Meihui
    Liu, Chao
    Wang, Bingrui
    Duan, Yongjuan
    Cheng, Xuelian
    Ruan, Min
    Zhang, Li
    Zou, Yao
    Chen, Yumei
    Yang, Wenyu
    Guo, Ye
    Chen, Xiaojuan
    Hu, Tianyuan
    Cheng, Tao
    Zhu, Xiaofan
    Zhang, Yingchi
    TRANSLATIONAL ONCOLOGY, 2021, 14 (08):
  • [46] Statistical validation of a threshold to discriminate flow-cytometry minimal residual disease (MRD) levels with prognostic significance in acute myeloid leukemia (AML).
    Buccisano, Francesco
    Maurillo, Luca
    Gattei, Valter
    Del Poeta, Giovanni
    Del Principe, Maria Ilaria
    Panetta, Paola
    Fraboni, Daniela
    Consalvo, Maria Irno
    Ottaviani, Licia
    Renzi, Daniela
    Faccia, Sabrina
    Sarlo, Chiara
    Lo Coco, Francesco
    Amadori, Sergio
    Venditti, Adriano
    BLOOD, 2006, 108 (11) : 651A - 652A
  • [47] Ultrasensitive circulating tumor DNA (ctDNA) minimal residual disease (MRD) detection in early stage non-small cell lung cancer (NSCLC)
    Isbell, James M.
    Goldstein, Jordan Scott
    Hamilton, Emily G.
    Liu, Si-Yang
    Eichholz, Jordan
    Buonocore, Darren J.
    Rusch, Valerie W.
    Bott, Matthew
    Molena, Daniela
    Rocco, Gaetano
    Yang, Soo-Ryum
    Rudin, Charles M.
    Jones, David R.
    Roff, Alanna
    Schultz, Andre
    Chabon, Jake J.
    Kurtz, David Matthew
    Alizadeh, Ash A.
    Li, Bob T.
    Diehn, Maximilian
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Utility of circulating tumor DNA (ctDNA) for detection of minimal residual disease (MRD) after curative-intent therapy in localized pancreatic cancer (PDAC)
    Yanala, Ujwal R.
    Martos, Mary
    Dickey, Erin M.
    Corona, Andres
    Ezenwajiaku, Nkiruka
    Pizzolato, Joseph
    Terrero, Gretel
    Hester, Caitlin A.
    Merchant, Nipun
    Hosein, Peter
    Datta, Jash
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S23 - S24
  • [49] Minimal residual disease (MRD) detection with circulating tumor DNA (ctDNA) from personalized assays in stage II-III colorectal cancer patients in a UK multicenter prospective study (TRACC)
    Anandappa, Gayathri
    Starling, Naureen
    Begum, Ruwaida
    Bryant, Annette
    Sharma, Shruti
    Renner, Derrick
    Aresu, Maria
    Peckitt, Clare
    Sethi, Himanshu
    Feber, Andrew
    Potter, Vanessa Alice
    Paraoan, Marius
    Abulafi, Muti
    George, Nicol
    Branagan, Graham
    Duff, Sarah
    West, Nicholas
    Aleshin, Alexey
    Chau, Ian
    Cunningham, David
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [50] Detection of Measurable Residual Disease (MRD) in Peripheral Blood: First Report of a Novel Microfluidic Platform in Patients with Acute Myeloid Leukemia (AML)
    Foster, Matthew C.
    Fedoriw, Yuri
    Pulley, Will
    Zeidner, Joshua
    Coombs, Catherine C.
    Mirkin, Emily
    Zomorrodi, Maryam
    Toughiri, Rachel
    Bartakova, Alena
    Carson, Craig
    Muller, Rolf
    Armistead, Paul M.
    BLOOD, 2019, 134
12345